During the past decade, Centre CARIO - HPCA conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 4 clinical trials were completed, i.e. on average, 11.8% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 4 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre CARIO - HPCA" #1 sponsor was "ARCAGY/ GINECO GROUP" with 11 trials, followed by "UNICANCER" with 4 trials sponsored, "Daiichi Sankyo, Inc." with 3 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre CARIO - HPCA" #1 collaborator was "AstraZeneca" with 4 trials as a collaborator, "Hoffmann-La Roche" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 3 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 3 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Centre CARIO - HPCA" are "Ovarian Cancer" (5 trials), "Breast Cancer" (3 trials), "Fallopian Tube Cancer" (3 trials), "Peritoneal Cancer" (3 trials) and "Endometrial Cancer" (2 trials). Many other conditions were trialed in "Centre CARIO - HPCA" in a lesser frequency.

Most popular intervention types in "Centre CARIO - HPCA" are "Drug" (33 trials), "Combination Product" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (7 trials), "Bevacizumab" (4 trials), "Gemcitabine" (4 trials), "Atezolizumab" (3 trials) and "Capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centre CARIO - HPCA" are 22 trials for "Female" genders, 13 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Centre CARIO - HPCA". undefined are not yet recruiting, 9 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Centre CARIO - HPCA, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centre CARIO - HPCA, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".